EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 22-Jun-2026 00:15 ET (22-Jun-2026 04:15 GMT/UTC)

Younger stroke survivors face greater concentration, mental health challenges — especially those not employed

University of Florida
Peer-Reviewed Publication

In a large study, younger stroke survivors reported more difficult concentrating and more poor mental health days

Journal: Geriatrics

Female reproductive cancers and the sex gap in survival

JAMA Network
Peer-Reviewed Publication

About The Study: In this population-level cohort study of 20 low-mortality countries, females ages 35 to 60 experienced disadvantage in cancer mortality compared with males—a consistent pattern observed across birth cohorts and over time. These findings underscore the ongoing need for action on the prevention, early detection, and treatment of early-onset female reproductive cancers.

Journal: JAMA Network Open

GLP-1RA switching and treatment persistence in adults without diabetes

JAMA Network
Peer-Reviewed Publication

About The Study: In this large cohort of adults with overweight or obesity without diabetes, fewer than 1 in 4 patients remained on any glucagon-like peptide-1 receptor agonist (GLP-1RA) after 12 months. Switching between GLP-1RA agents was common and may reflect active therapy management rather than nonengagement, particularly as new formulations and weight management agents emerge.

Journal: JAMA Network Open

Gnaw-y by nature: Researchers discover neural circuit that rewards gnawing behavior in rodents

University of Michigan
Peer-Reviewed Publication

This connection could also help explain why dogs chew bones and why people bite their nails.

Journal: Neuron

Most blood thinners safe to resume after flap surgery

University of Missouri-Columbia
Peer-Reviewed Publication

According to a new study from the University of Missouri School of Medicine, holding blood thinners for too long both before and after free flap reconstruction surgery could jeopardize the patient's outcome.

Journal: The Laryngoscope

UT San Antonio advances in national Blue Ridge rankings amid transformative year

The University of Texas at San Antonio Health Science Center
Grant and Award Announcement

In a year defined by transformation, The University of Texas at San Antonio (UT San Antonio) has emerged as a unified academic powerhouse, bringing together world-class research, clinical care and education under one banner. That momentum is now reflected in national measures of scientific impact.

P38 MAPK linked to epigenetic activation of fibrotic genes in senescent lung fibroblasts

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 10, 2026 — A new research paper was published in Volume 18 of Aging-US on March 3, 2026, titled “P38 MAPK is involved in epigenetic regulation of fibrotic genes in replication induced senescence in lung fibroblasts.”

Journal: Aging-US

Study identifies gene linked to chemotherapy resistance in prostate cancer

Weill Cornell Medicine
Peer-Reviewed Publication

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting. Given that taxanes remain the only chemotherapy agents with demonstrated survival benefit in advanced prostate cancer, understanding how and why resistance develops is an urgent need for patients.

Journal: Nature Communications

Review finds no evidence of benefit for ginkgo biloba in cognitive impairment; possible benefit in dementia

Georgetown University Medical Center
Peer-Reviewed Publication

An updated systematic review of dozens of studies finds that Ginkgo biloba may offer modest short-term improvements for people with dementia, but shows little to no benefit for individuals with subjective memory complaints, mild cognitive impairment, or multiple sclerosis-related cognitive problems. Across conditions, the supplement was not associated with an increased risk of serious harm compared to placebo.

Journal: Cochrane Database of Systematic Reviews